Correlation Between Coya Therapeutics, and Denali Therapeutics
Can any of the company-specific risk be diversified away by investing in both Coya Therapeutics, and Denali Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coya Therapeutics, and Denali Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Coya Therapeutics, Common and Denali Therapeutics, you can compare the effects of market volatilities on Coya Therapeutics, and Denali Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coya Therapeutics, with a short position of Denali Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coya Therapeutics, and Denali Therapeutics.
Diversification Opportunities for Coya Therapeutics, and Denali Therapeutics
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Coya and Denali is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Coya Therapeutics, Common and Denali Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Denali Therapeutics and Coya Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coya Therapeutics, Common are associated (or correlated) with Denali Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Denali Therapeutics has no effect on the direction of Coya Therapeutics, i.e., Coya Therapeutics, and Denali Therapeutics go up and down completely randomly.
Pair Corralation between Coya Therapeutics, and Denali Therapeutics
Given the investment horizon of 90 days Coya Therapeutics, Common is expected to generate 1.64 times more return on investment than Denali Therapeutics. However, Coya Therapeutics, is 1.64 times more volatile than Denali Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Denali Therapeutics is currently generating about -0.01 per unit of risk. If you would invest 580.00 in Coya Therapeutics, Common on September 10, 2024 and sell it today you would earn a total of 32.00 from holding Coya Therapeutics, Common or generate 5.52% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Coya Therapeutics, Common vs. Denali Therapeutics
Performance |
Timeline |
Coya Therapeutics, Common |
Denali Therapeutics |
Coya Therapeutics, and Denali Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Coya Therapeutics, and Denali Therapeutics
The main advantage of trading using opposite Coya Therapeutics, and Denali Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coya Therapeutics, position performs unexpectedly, Denali Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Denali Therapeutics will offset losses from the drop in Denali Therapeutics' long position.Coya Therapeutics, vs. Cue Biopharma | Coya Therapeutics, vs. Lantern Pharma | Coya Therapeutics, vs. Fennec Pharmaceuticals | Coya Therapeutics, vs. Eliem Therapeutics |
Denali Therapeutics vs. Bolt Biotherapeutics | Denali Therapeutics vs. Keros Therapeutics | Denali Therapeutics vs. Kezar Life Sciences | Denali Therapeutics vs. Replimune Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
Global Correlations Find global opportunities by holding instruments from different markets | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |